Superworth

OmniAb price to book ratio OABI

Market value divided by the book value of the company's net assets, since 2023.

Today, Nov 2, 2026
3.0×
4-year median
1.5×
Against its 4-year history
99th
percentile: 0 is its lowest day, 100 its highest
4-year range
0.6× to 3.0×
Peer median
7.3×

OmniAb's price to book ratio is 3.0× as of Nov 2, 2026.

That is above its 4-year median of 1.5×, higher than on 99% of days in the last 4 years.

Over that time it ranged from 0.6× in May 2025 to 3.0× in Oct 2026.

The median for 6 diagnostics and research stocks of a similar size is 7.3×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far3.0×0.8×3.0×
20251.0×0.6×1.6×
20241.5×1.5×2.3×
20232.2×1.2×2.2×

Against its peers

Companies in Medical - Diagnostics & Research nearest OmniAb's size, closest first, today.

CompanyPrice to book ratio
OABIOmniAb3.0×
NRCNRC Health81.9×
VCYTVeracyte2.8×
CDNACareDx9.7×
BLLNBillionToOne9.7×
ICCCImmucell3.1×
LNTHLantheus5.0×
Peer median7.3×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on OmniAb

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.